Twice, blood cancer has come for Lisa Livis’s family, and both times, research has met it with an answer. Lisa’s son Jason survived childhood leukaemia when a cure was far from guaranteed. Decades later, her husband Denis faced two separate blood cancers and ran out of standard options, only for new treatments to get him … Continued
On Thursday, 27 August, Snowdome Foundation welcomed supporters, researchers and members of the Snowdome community to the National Gallery of Victoria for The Art of Innovation, an evening exploring the future of CAR T-cell therapy and the transformative potential of Australian research. Guests heard from leading experts Dr Sam Fiorenza and Professor Jane Oliaro, whose … Continued
We are deeply saddened by the sudden passing of Sir Sam Neill. Sam was, of course, one of the world’s most celebrated and beloved actors, but he was also a passionate advocate for people living with blood cancer and a treasured member of our Snowdome community. Through his generosity and warm support, he helped shine … Continued
Snowdome Foundation has committed to a further two years of funding for world-first research led by Dr Adrian Minson at the Peter MacCallum Cancer Centre, aimed at optimising immunotherapy for aggressive B-cell lymphomas.
Research undertaken as part of the inaugural Snowdome Haematology Fellowship, awarded to Dr Josh Tobin in 2022 is set to have a transformative impact on frontline treatment for follicular lymphoma, offering more personalised, safer and effective treatment.
The Snowdome Foundation congratulates Dr Paniz Tavakoli and Dr Helen Cashman who have been announced as the 2025 Cannon Family Travel Grant recipients.
More than 200 guests joined us on Thursday 16 September for a spectacular evening under the dome at Snowball 2025.
We are pleased to provide an update on a pioneering research project to develop a new cellular immunotherapy for T-cell lymphoma.
Clinical trials make hope real for Australian blood cancer patients by transforming cutting-edge scientific findings into tangible treatment options.